GENESTONE 190 LITHOTRIPTER

FDA Premarket Approval P970062

Pre-market Approval Supplement Details

Approval for the genestone 190 lithotripter. This device is indicated for use in the non-invasive fragmentation of kidney (renal pelvic and renal calyceal) and upper ureteral stones between 5 and 20mm in size.

DeviceGENESTONE 190 LITHOTRIPTER
Generic NameLithotriptor, Extracorporeal Shock-wave, Urological
ApplicantBMT, INC.
Date Received1997-12-23
Decision Date1998-06-24
Notice Date1998-10-07
PMAP970062
SupplementS
Product CodeLNS 
Docket Number98M-0507
Advisory CommitteeGastroenterology/Urology
Expedited ReviewNo
Combination Product No
Applicant Address BMT, INC. 660 Main St. South suite 7 woodbury, CT 06798

Supplemental Filings

A PHP Error was encountered

Severity: Notice

Message: Undefined offset: 0

Filename: fda.report/pma_item.php

Line Number: 133

Backtrace:

File: /var/www/fda.report/pma_item.php
Line: 133
Function: _error_handler

Supplement NumberDateSupplement Type
P970062Original Filing

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.